By Jamie Grill-Goodman

Delta Dental of NJ and CT : Wilson to Retire , Di Maio Takes Reins

After 11 years as a transformative leader , Dennis G . Wilson , President and CEO of Delta Dental of New Jersey and Connecticut ( DDNJCT ), will retire from the company effective December 31 , 2024 . Paul Di Maio , currently Senior Vice President , General Counsel , and Chief Administrative Officer , will succeed Wilson as President and CEO , effective January 1 , 2025 .

Wilson joined DDNJCT as President and CEO in 2013 and under his guidance , DDNJCT has achieved impressive growth and become substantially more outwardly focused . Wilson created and launched a new corporate social responsibility program in his first year at the company , engaging with business , community , and charitable organizations at the board and executive team level throughout New Jersey and Connecticut .

Wilson also launched crucial strategic company initiatives , including a focus on individual and small group sales , establishing DDCT as a separate entity , and the addition of vision insurance to the DDNJCT portfolio . He also initiated the company ’ s unique small business and individual products , as well as the first Special Health Care Needs program in the market in support of individuals and families with disabilities . He will continue to be a part of the organization as a Special Advisor through June 30 , 2025 .

“ Leading DDNJCT has been a true privilege , and I am thankful for the hard work and cooperation of the Board and our associates in positioning the company for growth and continued success into the future ,” said Wilson .

Di Maio joined DDNJ in 2016 as Senior Vice President and General Counsel , providing guidance to the Board and management across all aspects of operations . In 2022 , he was appointed Chief Administrative Officer , where he successfully led the Legal , Compliance , Human Resources , Audit , and Special Investigations departments .

“ I look forward to working with our Board of Trustees , senior leadership , and our associates to build upon the success DDNJCT has achieved to this point . I especially thank Dennis for his leadership and the Board for its confidence in appointing me to this role ,” said Di Maio .

“ I ’ m honored to further my work with RWJBarnabas Health and Rutgers Cancer Institute in this new role ”

Trinitas Regional Medical Center Names First Hispanic Medical Director

RWJBarnabas Health and Rutgers Cancer Institute have named Gerardo Capo , MD as the Medical Director of Trinitas Comprehensive Cancer Center ( TCCC ) at Trinitas Regional Medical Center , an RWJBarnabas Health facility .

Dr . Capo is a medical oncologist treating all types of tumors with a particular interest in breast and gastrointestinal tumors . He will provide leadership and direction to enhance the quality , image and future growth of the oncology program .

Dr . Capo is also the first Hispanic medical director for the hospital , a significant factor as the hospital sits in a predominantly Hispanic and immigrant born area , allowing for a more comprehensive approach which properly meets the needs of the community .

“ I ’ m honored to further my work with RWJBarnabas Health and Rutgers Cancer Institute in this new role ,” said Dr . Capo . “ It is my hope to create an exceptional and cohesive experience for our patients as well as for the medical professionals who care for them . I believe in making patients feel like family , while working with my team to offer the most advanced treatment plans tailored to each patient .”

Prior to joining Trinitas Regional Medical Center , Dr . Capo completed a Fellowship in Hematology / Oncology at St . Vincent ' s Hospital in New York City , and a Fellowship in Pain and Palliative Care at Memorial Sloan Kettering Cancer Center . He has collaborated on many significant research papers and is currently principal investigator or co-investigator on several cancer clinical trials . Dr . Capo recently published an article in JAMA ( The Journal of the American Medical Association ) on the treatment of COVID patients , and is board-certified in medical oncology , hematology , palliative medicine and internal medicine .

Felician University Appoints Dean of Arts and Sciences

Felician University has appointed Dr . Tara E . Kent as the new Dean of the School of Arts and Sciences . Bringing over 25 years of experience in higher education to the position , she will

Continued

22 COMMERCE www . commercemagazinenj . com